LightCycler® MRSA Advanced Test for Rapid MRSA Detection in Referral Patients Admitted to Intensive Care Units

Article Sidebar

PDF
Published: Sep 20, 2014
DOI: https://doi.org/10.31524/bkkmedj.2013.09.004
Keywords:
methicillin resistant staphylococcus aureus, MRSA, LightCycler® MRSA advanced test

Main Article Content

Paithoon Boonma, MD
Sonchai Hiranniramol, MD
Kosin Thupvong, MD
Rapin Kukreja, MD
Chuchart Vinitwatanakhun, MD
Sawang Seanghiranvattana, MD
Siriporn Wittayachanyapong, MD
Pravich Tanyasittisuntorn, MD
Chanvit Shinawong, MD
Piemsak Prakardvudhisarn, MD
Arisara Suwanarit, RN
Achara Kongkittimakul, RN
Kunjana Saiam, MT

Abstract




OBJECTIVE: We studied the prevalence of Methicillin Resistant Staphylococcus Aureus (MRSA) nasal carrier in patients who were transferred and admitted to the intensive care unit (ICU).


MATERIALS AND METHOD: By using LightCycler® MRSA advanced test for the direct detection of MRSA DNA in nasal colonization by polymerase chain reaction (PCR) and comparing to standard MRSA isolated from plates culture media.


RESULTS: From December 2010 to May 2011, 100 patients were enrolled. They were referred to be admitted in ICUs of Bangkok Hospital Medical Center (BMC) (87), Samitivej Hospital Sukhumvit (12) and Bangkok Hospital Pattaya (1). Seventeen patients were excluded from the study. Of 83 patients, the light cycler MRSA test detected MRSA from an anterior nasal swab in 12 (14.5%) patients while concomitant plates culture grew MRSA in 10 (12.1%) (Kappa = 0.7913, 95% condence interval (CI) = 0.594-0.988).


CONCLUSION: The LightCycler® MRSA advanced test is a diagnostic test for rapid MRSA detection. The test aids in the detection of hospital infection and in the control of MRSA infections by rapid detection, therefore identifying the appropiate and isolated patient whom has MRSA colonization particularly in high risk patients.




Article Details

How to Cite
1.
Boonma P, Hiranniramol S, Thupvong K, Kukreja R, Vinitwatanakhun C, Seanghiranvattana S, Wittayachanyapong S, Tanyasittisuntorn P, Shinawong C, Prakardvudhisarn P, Suwanarit A, Kongkittimakul A, Saiam K. LightCycler® MRSA Advanced Test for Rapid MRSA Detection in Referral Patients Admitted to Intensive Care Units. BKK Med J [Internet]. 2014 Sep. 20 [cited 2024 Dec. 23];6(1):21. Available from: https://he02.tci-thaijo.org/index.php/bkkmedj/article/view/218117
Issue
Vol. 6 (2013): September
Section
Original Article

This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

References

1. Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007;298:1763-71.
2. National nosocomial infections surveillance system National Nosocomial Infection surveillance (NNIS) System Report. Data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470-85.
3. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin- Resistant Staphylococcus aureus Disease in Three Communities. N Engl J Med 2005;352:1436-44.
4. Inglis B, Matthews PR and Stewart PR. The Expression in Staphylococcus aureus of Cloned DNA Encoding Methicillin Resistance. J Gen Microbiol 1988;134:1465-9.
5. Tesch W, Strässle A, Berger-Bächi B, et al. Cloning and expression of methicillin resistance from Staphylococcus epidermidis in Staphylococcus carnosus. Antimicrob Agents Chemother 1988;32:1494-9.
6. Michel M, Gutmann L. Methicillin-resistant Staphylococus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities. Lancet 1997; 349:1901-1906.
7. Baba T, Takeuchi F, Kuroda M, et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 2002;359:1819-27.
8. Shitrit P, Gottesman BS, Katzir M, at al. Active surveillance for methicillin-resistant Staphylococcus aureus (MRSA) decreases the incidence of MRSA bacteremia. Infect Control Hosp Epidemiol 2006;27:1004-8.
9. Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 2003; 24:362-86.
10. LightCycler® MRSA Advanced Test For Use With The LightCycler® 2.0 Instrument. Manufactured by Roche Molecular System, Inc., NS 08876 USA. Doc Rev. 1.0 06369120001-01EN.
11. Boonma P. Improving handwashing method for controlling prevalence of MRSA in hospital. Bulletin of Nosocomial Infection Control Group of Thailand 2005;15:24.
12. Thompson RL, Cabezudo I, Wenzel RP. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med 1982;97:309-17.
13. Vriens M, Blok H, Fluit A, et al. Costs associated with a strict policy to eradicate methicillin-resistant Staphylococcus aureus in a Dutch University Medical Center: a 10-year survey. Eur J Clin Microbiol Infect Dis 2002; 21:782-6.
14. Kotilainen P, Routamaa M, Peltonen R, et al. Elimination of epidermic methicillin-resistant Staphylococcus aureus from a university hospital and district institutions. Finland. Emerg Infect Dis 2003;9:169.
15. Van Trijp, Melles DC, Hendriks WD, et al. Successful control of widespread methicillin-resistant Staphylococcus aureus colonization and infection in a large teaching hospital in the Netherlands. Infection Control and Hospital Epidemiology 2007;28:970.
16. Peterson LR, Liesenfeld O, Woods CW, et al. Multicenter evaluation of the LightCycler methicillin-resistant Staphylococcus aureus (MRSA) advanced test as a rapid method for detection of MRSA in nasal surveillance swabs. J Clin Microbiol 2010;48:1661-6.